Concepedia

WHJ Kruit

WK

3

Publications

156

Citations

3

H-Index

1995

Active since

Affiliations

Rotterdam University of Applied Sciences(Current)

Erasmus MC Cancer Institute

WHJ Kruit is an author at Rotterdam University of Applied Sciences specializing in medicine, immunology, and oncology.

Top concepts

MedicineOncologyImmunologyImmunotherapyUrologyDermatologyInflammationPharmacologyCancer TherapyPharmacotherapy

Publications per year

1995–1998

3

Publications

3

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients

Ronald de Wit, WHJ Kruit, G. Stoter et al. · British Journal of Cancer · 1998 · 112 citations · Full text

Metastatic Urothelial Cancer, Urology, Genitourinary Cancer +9

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma

WHJ Kruit, CJA Punt, SH Goey et al. · British Journal of Cancer · 1996 · 24 citations · Full text

High-dose Bolus Administration, Dose Efficacy Study, Medicine +8

Final report of a phase II study of interleukin 2 and interferon α in patients with metastatic melanoma

WHJ Kruit, SH Goey, F. Calabresi et al. · British Journal of Cancer · 1995 · 20 citations · Full text

Inflammation, Cytokine, Interleukin 2 +8

Rows per page

1–3 of 3